AUTHOR=Fu Yuting , Wang Wenjing , Zeng Qiao , Wang Ting , Qian Weidong 

TITLE=Antibiofilm Efficacy of Luteolin Against Single and Dual Species of Candida albicans and Enterococcus faecalis

JOURNAL=Frontiers in Microbiology

VOLUME=12

YEAR=2021

URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.715156

DOI=10.3389/fmicb.2021.715156

ISSN=1664-302X

ABSTRACT=<p><italic>Candida albicans</italic> and <italic>Enterococcus faecalis</italic> biofilm-associated infections have been a huge challenge to the medical community. However, the efficacy of natural products against mixed biofilms of <italic>C. albicans</italic> and <italic>E. faecalis</italic> still remains largely unexploited. The aim of this study was to evaluate the efficacy of luteolin against planktonic cell growth, adhesion, and biofilm formation of <italic>C. albicans</italic> and <italic>E. faecalis</italic> in single and mixed cultures <italic>in vitro</italic>. The results showed that the minimum inhibitory concentrations of luteolin against planktonic cells of <italic>C. albicans</italic>, <italic>E. faecalis</italic>, and mixed cultures were 32 and 64 μg ml<sup>–1</sup>, respectively. The results displayed that a remarkable variation in biofilm biomass, viability, structure, and composition of single and dual-species biofilms formed by mono- and dual-species biofilms of <italic>C. albicans</italic> and <italic>E. faecalis</italic> in the presence of luteolin was confirmed by mainly crystal violet staining assay (CVSA), optical microscope, field emission scanning electron microscope (FESEM), and confocal laser scanning microscope (CLSM). The tolerance of luteolin-treated single- and dual-species biofilms to antibiotics was found to obviously decrease, and the loss of biofilm matrix components (mainly polysaccharides and proteins) was revealed by CLSM. Moreover, luteolin was effective at inactivating biofilm cells, as well as destructing preformed biofilm structures by single and dual species by CVSA, FESEM, and CLSM. Collectively, these data indicate the potential of luteolin as a promising antibiofilm agent for the therapeutic management of biofilm-related infections induced by single and dual species of <italic>C. albicans</italic> and <italic>E. faecalis</italic>.</p>